Lung Cancer in Korea

Sehhoon Park¹, Chang-Min Choi², Seung-Sik Hwang³, Yoon-La Choi⁴, Hyae Young Kim⁵, Young-Chul Kim⁶, Young Tae Kim⁷, Ho Yun Lee⁸, Si Yeol Song⁹, Myung-Ju Ahn¹⁰

Affiliations

¹ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
² Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
³ Division of Public Health Science, School of Public Health, Seoul National University, Seoul, South Korea.
⁴ Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
⁵ Department of Diagnostic Radiology, National Cancer Center, Goyang, South Korea.
⁶ Lung Cancer Clinic, Pulmonary Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwangju, South Korea.
⁷ Seoul National University Cancer Research Institute, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, South Korea.
⁸ Department of Radiology and Center for Imaging, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
⁹ Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
¹⁰ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: silkahn@skku.edu.

PMID: 34809802
DOI: 10.1016/j.jtho.2021.09.007

Free article

Editorial

Lung Cancer in Korea

Sehhoon Park et al. J Thorac Oncol. 2021 Dec.

Free article

. 2021 Dec;16(12):1988-1993.

doi: 10.1016/j.jtho.2021.09.007.

Authors

Sehhoon Park¹, Chang-Min Choi², Seung-Sik Hwang³, Yoon-La Choi⁴, Hyae Young Kim⁵, Young-Chul Kim⁶, Young Tae Kim⁷, Ho Yun Lee⁸, Si Yeol Song⁹, Myung-Ju Ahn¹⁰

Affiliations

¹ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
² Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
³ Division of Public Health Science, School of Public Health, Seoul National University, Seoul, South Korea.
⁴ Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
⁵ Department of Diagnostic Radiology, National Cancer Center, Goyang, South Korea.
⁶ Lung Cancer Clinic, Pulmonary Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwangju, South Korea.
⁷ Seoul National University Cancer Research Institute, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, South Korea.
⁸ Department of Radiology and Center for Imaging, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
⁹ Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
¹⁰ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: silkahn@skku.edu.

PMID: 34809802
DOI: 10.1016/j.jtho.2021.09.007

No abstract available

PubMed Disclaimer

Cited by

Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption.
Poon C, Wilsdon T, Sarwar I, Roediger A, Yuan M. Poon C, et al. Front Public Health. 2023 Nov 9;11:1264342. doi: 10.3389/fpubh.2023.1264342. eCollection 2023. Front Public Health. 2023. PMID: 38026274 Free PMC article.
Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015.
Jeon DS, Kim HC, Kim SH, Kim TJ, Kim HK, Moon MH, Beck KS, Suh YG, Song C, Ahn JS, Lee JE, Lim JU, Jeon JH, Jung KW, Jung CY, Cho JS, Choi YD, Hwang SS, Choi CM; Korean Association for Lung Cancer; Korea Central Cancer Registry. Jeon DS, et al. Cancer Res Treat. 2023 Jan;55(1):103-111. doi: 10.4143/crt.2022.264. Epub 2022 Jun 20. Cancer Res Treat. 2023. PMID: 35790197 Free PMC article.
How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?
Hardavella G, Frille A, Chalela R, Sreter KB, Petersen RH, Novoa N, de Koning HJ. Hardavella G, et al. Eur Respir Rev. 2024 Jun 26;33(172):230232. doi: 10.1183/16000617.0232-2023. Print 2024 Apr. Eur Respir Rev. 2024. PMID: 38925794 Free PMC article. Review.
Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectives.
Li MSC, Mok KKS, Chan LL, Mok TSK. Li MSC, et al. J Liq Biopsy. 2023 Dec 12;3:100131. doi: 10.1016/j.jlb.2023.100131. eCollection 2024 Mar. J Liq Biopsy. 2023. PMID: 40026566 Free PMC article. Review.
Proton Pump Inhibitor Use and Its Association with Lung Cancer Likelihood and Mortality: A Nationwide Nested Case-Control Study in Korea.
Kwon MJ, Kang HS, Choi HG, Kim JH, Kim JH, Bang WJ, Yoo DM, Lee NE, Han KM, Kim NY, Hong S, Lee HK. Kwon MJ, et al. Cancers (Basel). 2025 Mar 4;17(5):877. doi: 10.3390/cancers17050877. Cancers (Basel). 2025. PMID: 40075724 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Lung Cancer in Korea

Affiliations

Lung Cancer in Korea

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical